Pardes Biosciences Cash And Equivalents vs. Shares Owned By Institutions

PRDSDelisted Stock  USD 2.14  0.01  0.47%   
Based on Pardes Biosciences' profitability indicators, Pardes Biosciences may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Pardes Biosciences' ability to earn profits and add value for shareholders.
For Pardes Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pardes Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pardes Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pardes Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pardes Biosciences over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Please note, there is a significant difference between Pardes Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pardes Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pardes Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Pardes Biosciences Shares Owned By Institutions vs. Cash And Equivalents Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Pardes Biosciences's current stock value. Our valuation model uses many indicators to compare Pardes Biosciences value to that of its competitors to determine the firm's financial worth.
Pardes Biosciences is regarded fifth in cash and equivalents category among its peers. It is regarded fourth in shares owned by institutions category among its peers . The ratio of Cash And Equivalents to Shares Owned By Institutions for Pardes Biosciences is about  3,172,797 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Pardes Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Pardes Shares Owned By Institutions vs. Cash And Equivalents

Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Pardes Biosciences

Cash

 = 

Bank Deposits

+

Liquidities

 = 
228.6 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Pardes Biosciences

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
72.05 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Pardes Shares Owned By Institutions Comparison

Pardes Biosciences is currently under evaluation in shares owned by institutions category among its peers.

Pardes Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Pardes Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pardes Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Pardes Biosciences' change in net profit over the period of time. It can combine multiple indicators of Pardes Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. The company was incorporated in 2020 and is headquartered in Carlsbad, California. Pardes Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.

Pardes Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Pardes Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pardes Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pardes Biosciences' important profitability drivers and their relationship over time.

Use Pardes Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pardes Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pardes Biosciences will appreciate offsetting losses from the drop in the long position's value.

Pardes Biosciences Pair Trading

Pardes Biosciences Pair Trading Analysis

The ability to find closely correlated positions to Pardes Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pardes Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pardes Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pardes Biosciences to buy it.
The correlation of Pardes Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pardes Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pardes Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pardes Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Pardes Biosciences position

In addition to having Pardes Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Agriculture Thematic Idea Now

Agriculture
Agriculture Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Agriculture theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agriculture Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Consideration for investing in Pardes Stock

If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stocks Directory
Find actively traded stocks across global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum